Investment
Features
FeesSafety
Academy
More
Pluang+

Compare General Mills, Inc. (GIS) vs Tilray Brands Inc (TLRY) Price & Performance

General Mills, Inc.Trade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

General Mills, Inc. vs Tilray Brands Inc — how do they compare? General Mills, Inc. trades at $32.1 (market cap $17.43B), while Tilray Brands Inc trades at $3.49 (market cap $530.54M). The key difference: General Mills, Inc. is far larger — about 32.9× Tilray Brands Inc's market cap, and General Mills, Inc. pays a 7.49% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Mills, Inc. for 106 Days and Tilray Brands Inc for 31 Days on average.

GISTLRY
Market Cap
$17.43B$530.54M
Volume
16,554,3629,099,075
Sector
Consumer StaplesHealth
52-Week High
$49.36$21.00
52-Week Low
$31.67$3.57
Typical Hold Time
106 Days31 Days
Enterprise Value
$30.61B$684.46M
Dividend Yield
7.49%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

General Mills, Inc.

General Mills (GIS) trades at $32.09, up 1.01% with mixed technical signals showing bearish moving averages but neutral oscillators. The company faces fundamental challenges with a negative net income margin of -4.89% and ROE of -10.55% for 2026, though it maintains strong operating cash flow of $2.92B in 2025. Recent leadership transition to Dana McNabb as CEO and a $3B cost-saving initiative aim to stabilize performance amid declining revenues.

The stock presents a value opportunity with a low P/E of 9.23 and a 7.6% upside to the $36 consensus target, supported by a reliable dividend. However, risks include persistent margin pressures, high debt levels at 45% of assets, and competitive headwinds in the packaged foods sector. Analyst sentiment is cautious with 61% hold ratings, reflecting uncertainty around the turnaround strategy's execution.

Tilray Brands Inc

TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.

TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GIS
100% Buy0% Sell
Avg holding period · 106 Days
TLRY
100% Buy0% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About General Mills, Inc.

General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.

Read more on GIS →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →